Fungal infections
Type I Interferons Are Essential for Early Control of Candida albicans in Vulvovaginal Candidiasis
Absence of IFN-I Signaling Increases Fungal Burden and Inflammation
Vulvovaginal Candidiasis: Causes, Pathogenesis, Treatment
How the Body Interacts with Fungus in Acute and Recurrent Vulvovaginal Candidiasis
PD-L1: A Receptor Activating Immune Response to Fungal Infections
PD-L1 Binds to Yeast Protein Rpl20b During Phagocytosis
Vitamin D Deficiency Increases The Risk of Oral Candidiasis
Study on patients with HIV infection
Vitamin D3 Suppresses Candida Biofilm Formation
Reduced Biofilm Formation Enhances Antifungal Therapy Efficacy
Interferon α2b and Vitamin D Reduce Inflammation in Vaginal Infections in Pregnancy
Influence of complex therapy on the balance of cytokines
Interrelation between Oral Candidiasis and Diabetes Mellitus
Decreased interferon-gamma and increased IL-10 increase the risk of Candida
Vitamin D3 – A New Remedy against Fungal Infections
Vitamin D3 destroys Candida and reduces the risk of systemic thrush
COVID-19 Complication: Facial Nerve Palsy Associated with Fungal Infection
Immunosuppression in COVID-19 contributes to the development of mucormycosis
Fungal Infections with Coronavirus
Candida fungus linked to COVID-19 deaths
A Delicate Balance of Type I Interferon Defeats Fungus
Impaired interferon response contributes to inflammation and severe fungal infections
Type I Interferons in Fungal Infections
How interferon affects invasive, non-invasive mycoses and fungal superinfections
Interferons to Treat Fungal Infections
Interferon enhances the effect of antifungal drugs
Interferon-Alpha-2b Improves The Effect of Antifungal Drugs in Thrush Treatment
Interferon enhances the immune response in vulvovaginal candidiasis
Interferon-gamma for the treatment of fungal infections
Interferon-gamma activates the immune system and enhances the action of antifungal drugs
Interferons in the pathogenesis of fungal diseases
Interferon activates the antifungal immune response